METLIFE INC

For the period ended Dec 31, 2024. Filed Feb 21, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 21, 2025

MET$101.67+3.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations

(In millions, except per share data)

	2024	2023	2022
Revenues
Premiums	$44,945	$44,283	$48,510
Universal life and investment-type product policy fees	4,974	5,152	5,225
Net investment income	21,273	19,908	15,916
Other revenues	2,601	2,526	2,630
Net investment gains (losses)	(1,184)	(2,824)	(1,260)
Net derivative gains (losses)	(1,623)	(2,140)	(2,251)
Total revenues	70,986	66,905	68,770
Expenses
Policyholder benefits and claims	44,728	44,590	49,507
Policyholder liability remeasurement (gains) losses	(206)	(45)	114
Market risk benefit remeasurement (gains) losses	(1,109)	(994)	(3,674)
Interest credited to policyholder account balances	8,339	7,860	3,894
Policyholder dividends	595	622	706
Other expenses	13,017	12,710	11,859
Total expenses	65,364	64,743	62,406
Income (loss) before provision for income tax	5,622	2,162	6,364
Provision for income tax expense (benefit)	1,178	560	1,062
Net income (loss)	4,444	1,602	5,302
Less: Net income (loss) attributable to noncontrolling interests	18	24	18
Net income (loss) attributable to MetLife, Inc.	4,426	1,578	5,284
Less: Preferred stock dividends	200	198	185
Net income (loss) available to MetLife, Inc.’s common shareholders	$4,226	$1,380	$5,099

Net income (loss) available to MetLife, Inc.’s common shareholders per common share:
Basic	$5.98	$1.82	$6.35
Diluted	$5.94	$1.81	$6.30

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.